Lucid Diligence Brief: Vyriad $25M Series B to take in-vivo CAR-T into clinic
Lucid Diligence Brief: Vyriad $25M Series B to take in-vivo CAR-T into clinic…
Lucid Diligence Brief: Bristol Myers Squibb's acquisition of Orbital Therapeutics
Lucid Diligence Brief: Bristol Myers Squibb's acquisition of Orbital…
Latest Immunology News - Sept 25th to Oct 8th 2025
Watch Our Video Summary Capturing Top Immunology News from the Last Two Weeks…
Cell and Gene Therapy Weekly News - October 2nd 2025
Gene & Cell Therapy Update: eXmoor × Siam Bioscience Partnership, FDA Fast…
Immunology Weekly News - October 1st 2025
Immunology Update: EndoQuest Robotics, $1.8M NIH grant, BMS Patient Connect and…